Western blot assay showed that LMX1A was up‐regulated in glioma tissues and cell lines compared with NBTs and NHA, moreover, the expression level was positively correlated with pathological grades of glioma (Figure 4A‐B). This evidence concerns the gene LMX1A and central nervous system cancer.